KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Clinical trial NCT05603572 · SUSPENDED

Trial details

NCT number: NCT05603572
Sponsor: Primocure Pharma
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Fibrolamellar Carcinoma

Start date: 2022-11-01
Primary completion: 2027-11-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.